NSABP Members' Area
Password Protected - Access
Limited to NSABP Participating
Institutions Only
NSABP Foundation, Inc.
General NSABP Information
Contact the NSABP
Pathology Section
Future Meetings
NSABP Newsletters
Media Info on cMYC Study
Media Info on STAR
Employment
Clinical Trials Information
Clinical Trials Overview
Protocol Chart
Never Say Lost
Treatment Trials Information
Protocol B-37
Protocol B-39
Protocol B-40
Protocol B-41
Protocol B-42
Protocol B-43
Protocol BP-59
Protocol R-04
Prevention Trials Information
Protocol P-1 - BCPT
Protocol P-2 - STAR
BreastCancerPrevention.com
Bibliography of Publications
Related Web Sites
About the NSABP Web Site
Medical Search Engines
To report problems, ask
questions or make comments,
please send e-mail to:
Webmaster@nsabp.pitt.edu
Protocol P-2 (STAR)
The Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Specific Aims
This study will determine if raloxifene is either more or less effective than tamoxifen in reducing the incidence of invasive breast cancer in postmenopausal women who are at increased risk for the disease. A secondary goal is to determine whether raloxifene reduces the endometrial cancer rate compared to tamoxifen.
